SEARCH

SEARCH BY CITATION

References

  • 1
    Rauws E & Tytgat G. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 12335.
  • 2
    Tytgat G, Noach L, Rauws E. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993; 22: 12739.
  • 3
    Miehlke S, Bayerdorffer E, Lehn N, et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 9758.
  • 4
    Hopkins R, Girardi L, Tumey E. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 124452.
  • 5
    Axon A, O'Morain C, Bardhan K, et al. Randomized double-blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997; 314: 5658.
  • 6
    Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Helicobacter pylori eradication reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 14.
  • 7
    Macri G, Milani S, Surrenti E, Passaleva M, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long term follow-up study. Am J Gastroenterol 1998; 93: 9257.
    Direct Link:
  • 8
    Anonymous. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997; 41: 813.
  • 9
    Huang J & Hunt R. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol Ther 1999; 13: 71929.DOI: 10.1046/j.1365-2036.1999.00530.x
  • 10
    McColm A, McLaren A, Klinkert G, et al. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate–ranitidine admixture. Aliment Pharmacol Ther 1996; 10: 24150.
  • 11
    Van Oijen A, Verbeek A, Jansen J, De Boer WA. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based tripletherapies. Aliment Pharmacol Ther 2000; 14: 9919.DOI: 10.1046/j.1365-2036.2000.00798.x
  • 12
    Laheij R, Rossum L, Jansen J, Straatman H, Verbeek A. Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta-analysis. Aliment Pharmacol Ther 1999; 13: 85764.DOI: 10.1046/j.1365-2036.1999.00542.x
  • 13
    Pipkin G, Williamson R, Wood J. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 82337.DOI: 10.1046/j.1365-2036.1998.00405.x
  • 14
    Dore M, Leandro G, Realdi G, Sepulveda A, Graham D. Effect of pre-treatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy. A meta-analytical approach. Dig Dis Sci 2000; 45: 6876.
  • 15
    Houben M, Van der Beek D, Hensen E, Craen A, Rauws E, Tytgat G. A systematic review of Helicobacter pylori eradication therapy—The impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999; 13: 104755.DOI: 10.1046/j.1365-2036.1999.00555.x
  • 16
    Van der Wouden E, Van Thijs J, Zwet A, Sluiter W, Kleibeuker J. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 1999; 94: 17519.
  • 17
    Bardhan K, Morton D, Perry M, et al. Ranitidine bismuth citrate with clarithromycin given alone or with metronidazole for 7 days effectively eradicates Helicobacter pylori. Gastroenterology 1998; 114: A66A66(Abstract).
  • 18
    Van der Wouden E, Thijs J, Zwet A, Kooy A, Kleibeuker J. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13: 297302.DOI: 10.1046/j.1365-2036.1999.00486.x
  • 19
    Vakil N, Hahn B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol 1998; 93: 14325.
    Direct Link:
  • 20
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 62934.
  • 21
    Miettinen O. Theoretically Epidemiology, Principles of Occurrence Research in Medicine. New York: Delmar Publishing, 1985.
  • 22
    Battaglia G, Di Mario F, Leandro G, et al. Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules. Helicobacter 1998; 3: 1159.DOI: 10.1046/j.1523-5378.1998.08035.x
  • 23
    Deltenre M, Van Jonas C, Gossum M, Buset M, Otero J, De Koster E. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): S3944.
  • 24
    Gisbert J, Boixeda D, De Argila C, Bermejo F, Redondo C, De Rafael L. Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics. Eur J Gastroenterol Hepatol 1997; 9: 95762.
  • 25
    Gisbert J, Boixeda D, Martín de Argila C, Álvarez Baleriola A, Abraira V, García Plaza A. Unhealed duodenal ulcers despite Helicobacter pylori eradication. Scand J Gastroenterol 1997; 32: 64350.
  • 26
    Labenz J, Tillenburg B, Peitz U, et al. Ulcusheilung durch Helicobacter-pylori-Eradikation: Genügt eine Woche Therapie? Dtsch Med Wochenschr 1996; 121: 38.
  • 27
    Pérez Mota A, Alberdi JM, Pita L, et al. Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. Rev Esp Enferm Dig 1997; 89: 87984.
  • 28
    Fennerty M, Lieberman D, Magaret N. Effectiveness of H. pylori treatment regimes in clinical practice; a community-based outcomes study. Gastroenterology 1997; 112: A14A14(Abstract).
  • 29
    Johnston B & Levi S. What is the relevance of the randomised controlled clinical trial in H. pylori eradication to routine clinical practice? Gut 1997; 41(Suppl. 3): A166A166(Abstract).
  • 30
    Katelaris P, Nguyen T, Robertson G. Efficacy of repeat treatments after initial failure of Helicobacter pylori eradication therapy. Gastroenterology 1999; 116: A205A205(Abstract).
  • 31
    Oderda G, Caristo P, Kuvidi M, et al. Evaluation of different treatment schedules in childhood Helicobacter pylori gastritis: a 10 year experience. Gut 1999; 45(Suppl. 3): A94A94(Abstract).
  • 32
    Oderda G, Lerro P, Caristo P, et al. Triple therapy with omeprazole and two antibiotics in children with Helicobacter pylori gastritis. Gut 1996; 39(Suppl.3): A71A71(Abstract).
  • 33
    Passigato N, Biti L, Marconi I, et al. Comparison of three alternative strategies for Helicobacter pylori eradication in patients with chronic gastritis. Gut 1997; 41(Suppl. 3): A210A210(Abstract).
  • 34
    Reilly T, Poxon P, Walt R. The eradication of Helicobacter pylori in practice: an audit of three years clinical experience with peptic ulcer patients. Gut 1995; 37(Suppl. 1): A87A87 (Abstract).
  • 35
    Zullo A, Rinaldi V, Hassan C, et al. Different Helicobacter pylori eradication rates between non-ulcer dyspepsia and peptic ulcer patients. Gut 1998; 43(Suppl. 2): A92A92(Abstract).
  • 36
    Mach T & Zahradnik-Bilska J. Reinfekcja Helicobacter pylori u chorych z wrzodem dwunastnicy pro przebytej skutecznej eradykacji. Pregl Lek 1999; 56: 47782.
  • 37
    Laurent J, Megraud F, Flejou J, Caekaert A, Barthelemy P. Comparison of 4 triple therapies combining omeprazole and 2 antibiotics for the eradication of Helicobacter pylori (H. pylori). Interest of bacampicilline and azithromycin. Gastroenterology 1999; 116: A120A120(Abstract).
  • 38
    Yang J, Shun C, Yang C, et al. A multicenter study of lansoprazole combined with antibiotics to eradicate Helicobacter pylori infection in the patients with duodenal ulcer. Gut 1997; 41(Suppl. 1): A99A99(Abstract).
  • 39
    Bhasin D, Sharma B, Sinha S, et al. Comparison of multidrug regimens for eradication of Helicobacter pylori. Gastroenterology 1999; 116: A123A123(Abstract).
  • 40
    Bénitez J, Perez M, Galdón S, et al. Short course treatment to eradicate H. pylori in 246 patients with peptic ulcer disease. Gut 1997; 41(Suppl. 1): A105A105(Abstract).
  • 41
    Lau C, Wong A, Loo C, Lam K. Comparison of two one-week triple therapy regimens for Helicobacter pylori eradication in a public hospital of Hong Kong. World Congress of Gastroenterology1998; Abstracts-on-disk.
  • 42
    Lee S, Kim C, Chun H, et al. Assessment of Helicobacter pylori eradication in the limited availability: is it possible? Gut 1997; 41(Suppl. 3): A213A213(Abstract).
  • 43
    Pieramico O & Zanetti M. Role of metronidazole and clarithromycin resistance on the outcome of omeprazole-based triple therapies for H. pylori eradication. Gut 1999; 45(Suppl. 3): A116A116(Abstract).
  • 44
    Takáts A, Gero G, Szentmihályi A. One-week triple therapy for eradication of Helicobacter pylori (with ranitidine bismuth citrate, clarithromycin [250 or 500 mg] and amoxicillin or tinidazole). Gastroenterology 2000; 118: A1313A1313(Abstract).
  • 45
    Fock K, Chelvam P, Lim S. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. Aliment Pharm Ther 2000; 14: 22531.
  • 46
    Uygun A, Ates Y, Erdil A, et al. Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. Clin Ther 1999; 21: 153948.DOI: 10.1016/s0149-2918(00)80009-0
  • 47
    Houben M, Hensen E, Rauws E, et al. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or susceptible Helicobacter pylori strains. Aliment Pharmacol Ther 1999; 13: 8839.DOI: 10.1046/j.1365-2036.1999.00565.x
  • 48
    Pilotto A, Franeceschi M, Leandro G, et al. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. J Gastroenterol Hepatol 1999; 14: 46875.DOI: 10.1046/j.1440-1746.1999.01893.x
  • 49
    Malfertheiner P, Bayerdörffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infections in patients with gastric ulcer. Aliment Pharmacol Ther 1999; 13: 70312.DOI: 10.1046/j.1365-2036.1999.00535.x
  • 50
    Cammarota G, Cianci R, Gasbarrini G. Eradication of Helicobacter pylori in routine clinical practice: doubts and uncertainties. Hepatogastroenterology 1999; 46: 3125.
  • 51
    Pilotto A, Leandro G, Franceschi M, et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999; 13: 66773.DOI: 10.1046/j.1365-2036.1999.00508.x
  • 52
    Neville P, Everett S, Langworthy H, et al. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther 1999; 13: 497501.DOI: 10.1046/j.1365-2036.1999.00493.x
  • 53
    Lee J, Breslin N, Hyde D, Buckley M, O'Morain C. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999; 13: 48996.DOI: 10.1046/j.1365-2036.1999.00504.x
  • 54
    Veldhuyzen van Zanten S, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 28995.DOI: 10.1046/j.1365-2036.1999.00471.x
  • 55
    Gisbert J, Boixeda D, Aller R, et al. Helicobacter pylori y hemorragia digestiva por ulcera duodenal: prevalencia de la infeccion, eficacia de tres terapias triples y papel de la erradicacion en la prevencion de la recidiva hemorragica. Med Clin Barc 1999; 112: 1615.
  • 56
    Lind T, Mégraud F, Unge P, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 24853.
  • 57
    Gisbert J, Boixeda D, Bermejo F, et al. Omeprazol más dos antibióticos para la erradición de H. pylori, ?son suficientes cinco días de tratiamento? Rev Clin Esp 1998; 198: 6559.
  • 58
    Stack W, Knifton A, Thirlwell D, et al. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. Am J Gastroenterol 1998; 93: 190913.
    Direct Link:
  • 59
    Perri F, Clemente R, Festa V, et al. Relationships between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1998; 30: 14650.
  • 60
    Goh K, Parasakthi N, Chuah S, Cheah P, Lo Y, Chin S. Comparison of two 1-week low-dose omeprazole triple therapies—optimal treatment for Helicobacter pylori infection? Aliment Pharmacol Ther 1997; 11: 11158.
  • 61
    Misiewicz J, Harris A, Bardhan K, et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 1997; 41: 7359.
  • 62
    Laine L, Frantz J, Baker A, Neil G. A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther 1997; 11: 9137.
  • 63
    Lind T, Van Veldhuyzen Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996; 1: 13844.
  • 64
    Tursi A, Cammarota G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 2858.
  • 65
    Gasbarrini A, Ojetti V, Pitocco D, et al. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. Scand J Gastroenterol 2000; 35: 2603.
  • 66
    Bazzoli F, Zagari R, Pozzato P, et al. Efficacy of lansoprazole in association with clarithromicyn and metronidazole or amoxycillin for Helicobacter pylori eradication. Gastroenterology 1998; 114: A70A70(Abstract).
  • 67
    Dehesa M, Larisch J, Di Silvio M, et al. Comparison of three 7 days pantoprazole based Helicobacter pylori eradication schemes in a mexican population with highly metronidazole resistant Hp strains. Gastroenterology 1998; 114: A99A99 (Abstract).
  • 68
    Jonas C, Dereuck M, Van Otero J, Gossum M, Deltenre M. Low-dose, one-week triple therapy for Hp: a randomized study. Gastroenterology 1996; 110: A145A145(Abstract).
  • 69
    Lamouliatte H, Cayla R, Talbi P, Zerbib F, Mégraud F, De Mascarel A. Randomised study comparing two seven days triple therapies with lansoprazole and low dose of clarithromycin plus amoxicillin or tinidazole for Helicobacter pylori eradication. Gut 1996; 39(Suppl. 2): A35A35(Abstract).
  • 70
    Sue M, Peura D, Charles C, et al. Comparison of two treatment strategies for the eradication of H. pylori utilizing a screening antibody serum blot test and confirmatory c 14 breath test. Gastroenterology 1996; 110: A266A266 (Abstract).
  • 71
    Frevel M, Daake H, Janisch H, et al. Pantoprazole plus clarythromycin and metronidazole versus pantoprazole plus clarythromycin and amoxycillin for therapy of H. pylori infection. Gut 1997; 41(Suppl. 1): A103A103(Abstract).
  • 72
    Pieramico O, Zanetti M, Innerhofer M. High-dosage omeprazole-based triple therapy for the eradication of H. pylori infection: a randomised trial. Gastroenterology 1998; 114: A258A258(Abstract).
  • 73
    Paoluzi P, Rossi P, Consolazio A, et al. A single-blind monocentric study of four treatments for H. pylori eradication: an interim report. Gastroenterology 1998; 114: A252A252(Abstract).
  • 74
    Michopoulos S, Bouzakis H, Balta A, et al. Randomized study comparing three different triple regimens containing clarithromycin for H. pylori (Hp) eradication in patients with duodenal ulcer. Gut 1997; 41(Suppl. 3): A209A209 (Abstract).
  • 75
    Jaup B, Stenquist B, Norrby A. One-week b.i.d. therapy for H. pylori: a randomised comparison of three strategies on clinical outcome and side-effects. Gut 1997; 41(Suppl. 3): A209A209(Abstract).
  • 76
    Tzathas C, Petraki K, Amberiadis P, et al. A prospective, randomised, controlled, investigator-blind, single-centre trial comparing two one-week omeprazole triple therapies for healing peptic ulcer and eradication of Helicobacter pylori infection. Gut 1998; 43(Suppl. 2): A91A91(Abstract).
  • 77
    Lamouliatte H, Mégraud F, Forestier S, Laurence M. Comparison of two one-week triple therapies with a low dose of lansoprazole and two low dose antibiotics in Helicobacter pylori eradication: a French study. Gastroenterology 1998; 114: A194A194(Abstract).
  • 78
    Perri F, Festa V, Clemente R, Quitadamo M, Andriulli A. Failure of standard triple therapies for H. pylori eradication in dyspeptic outpatients. Gut 1999; 45(Suppl. 3): A113A113 (Abstract).
  • 79
    Di Mario F, Dal Bo′ N, Battaglia G, et al. Pantoprazole in eradication of peptic ulcer (H. pylori) positive patients: a multicentre randomised prospective study by GISU (interdisciplinary ulcer study group). Gut 1999; 45(Suppl. 3): A113A113(Abstract).
  • 80
    Lee C, Wu C, Chen T, et al. Comparison of metronidazole or amoxycillin based 1-week low dose triple therapy in the treatment of active duodenal ulcer: can pre-treatment urea breath test values predict the outcome? Gut 1999; 45(Suppl. 3): A119A119(Abstract).
  • 81
    Unge P, Kimaura K, Sipponen P, et al. Is the efficacy of H. pylori therapy similar in Japanese and Swedish patients? A single blind randomised head-to-head comparison. Gut 1999; 45(Suppl. 3): A52A52(Abstract).
  • 82
    Takáts A, Szentmihályi A, Gerö G. Efficacy of one week pantoprazole containing triple therapies for eradication of Helicobacter pylori. Gut 1999; 45(Suppl. 5): A275A275(Abstract).
  • 83
    Neville P, Axon A, Moayyedi P. Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for Helicobacter pylori eradication—Results of a single-blinded randomised trial in the community. Gastroenterology 1999; 116: A266A266(Abstract).
  • 84
    Cammarota G, Cannizaro O, Ojetti V, et al. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 737.DOI: 10.1046/j.1365-2036.2000.00664.x
  • 85
    Sung J, Chan F, Wu J, et al. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. Aliment Pharmacol Ther 1999; 13: 107984.DOI: 10.1046/j.1365-2036.1999.00580.x
  • 86
    Cammarota G, Cannizaro O, Tursi A, et al. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Aliment Pharmacol Ther 1998; 12: 53943.DOI: 10.1046/j.1365-2036.1998.00341.x
  • 87
    Ricciardiello L, Cannizzaro O, D'Angelo A, et al. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. Aliment Pharmacol Ther 1998; 12: 5337.DOI: 10.1046/j.1365-2036.1998.00342.x
  • 88
    Wetterhus S, Boixeda D, Altorjay I, Federico R, Vanweerts S, Duggan A. Ranitidine bismuth citrate with low-dose clarythromycin and metronidazole for one week gives high rates of H. pylori eradication. Gastroenterology 1998; 114: A330A330(Abstract).
  • 89
    Crawford J, Meyer J, Herm-Barabasz R, Goldstein J. Two open-label efficacy trials of ranitidine bismuth citrate (RBC) in combination with clarithromycin (C) and amoxicillin (A) or metronidazole (M) for Helicobacter pylori (Hp) eradication. Gastroenterology 1998; 114: A95A95(Abstract).
  • 90
    Hetzel D, Dekkers C, Coremans G, Vanweerts S, Duggan A. Ranitidine bismuth citrate (Pylorid) with low dose clarythromycin and metronidazole twice daily for one week gives high rates of H. pylori eradication. Gut 1997; 41(Suppl. 3): A206A206(Abstract).
  • 91
    Susi D. Cost and efficacy of 7-day triple therapies for Helicobacter pylori eradication: PPI-based vs RBC-based regimens. Gut 1999; 45(Suppl. 3): A106A106(Abstract).
  • 92
    Imperiale T. Meta-analysis: When and how. Hepatology 1999; 29(Suppl. 1): 26S31S.
  • 93
    Egger M, Smith G, Phillips A. Meta-analysis: Principles and procedures. Br Med J 1997; 315: 15337.
  • 94
    Egger M & Smith G. Meta-analysis: bias in location and selection of studies. Br Med J 1998; 316: 616.
  • 95
    Lamouliatte H, Samoyeau R, De Mascarel A, Mégraud F. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1999; 13: 152330.DOI: 10.1046/j.1365-2036.1999.00646.x
  • 96
    Calvet X, García N, López T, Gisbert J, Gené E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 6039.DOI: 10.1046/j.1365-2036.2000.00744.x
  • 97
    Savarino V, Zentilin P, Pivari M, et al. The impact of antibiotic resistance on the efficacy of three 7-day triple regimens against H. pylori infection. Aliment Pharmacol Ther 2000; 14: 893900.DOI: 10.1046/j.1365-2036.2000.00780.x
  • 98
    Mégraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998; 115: 127882.
  • 99
    Graham D. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998; 115: 12727.
  • 100
    European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 77781.
  • 101
    Llenrieder V, Boeck W, Richter C, Marre R, Adler G, Glasbrenner B. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999; 34: 7506.
  • 102
    Friedman C, Gold B, Zirnstein G, et al. Helicobacter pylori antimicrobial resistance in the United States: preliminary results of a 9-center study. Gastroenterology 2000; 118: A699A699(Abstract).
  • 103
    De Boer WA & Tytgat G. Treatment of Helicobacter pylori infection. Br Med J 2000; 320: 314.
  • 104
    Buckley M, Xia H, Hyde D, Keane C, O'Morain C. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig Dis Sci 1997; 42: 21115.
  • 105
    Goddard A, Logan R, Atherton J, Hawkey C, Spiller R. Maastricht consensus report regimen for second line treatment of Helicobacter pylori infection: How does it perform in practice? Gut 1997; 41(Suppl. 1): A104A104(Abstract).